Delivery Order SPE2DB24D3015-SPE2DB24FFWUQ

Award Date 7/1/24
Potential Completion Date 7/23/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $77,920.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S, with a completion date of November 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The award has a ceiling value of $8,123.96 and a completion date of May 30, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. AmerisourceBergen Drug...
This federal contract award is for the delivery of IBRANCE 125 MG CAPSULE 21S pharmaceuticals to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,792.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a period of performance through September 17, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA...
This federal contract award is for the delivery of IBRANCE 100 MG CAPSULE 21S pharmaceutical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp. The firm-fixed-price delivery order, valued at $31,185.24, has a period of performance through December 4, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this contract, which is not designated as a set-aside. The contract is issued under...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,792.08 firm-fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,127.13 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $7,797.84 in firm-fixed-price delivery orders for IBRANCE 75 MG CAPSULE 21S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a July 2024 completion date and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical...
This federal contract award is a delivery order with a ceiling value of $7,792.08, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S to the Department of Defense (DoD). The contract has a ceiling value of $7,792.08 and is a Firm-Fixed-Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025, which...
The federal contract award described is for the delivery of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S to the U.S. government. The contract, valued at $7,792.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract was awarded by the Department of Defense's Medical Supply Chain division, and the award indicates that Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB24FFWUQ
    Delivery Order

This federal contract award is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award, valued at $7,792.08, is a delivery order contract with a firm-fixed price.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract does not have a set-aside designation.

Generated 9/30/24, 11:14 AM